We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical and laboratory features of seventy‐eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).
- Authors
Zaman, M.; Huissoon, A.; Buckland, M.; Patel, S.; Alachkar, H.; Edgar, J. D.; Thomas, M.; Arumugakani, G.; Baxendale, H.; Burns, S.; Williams, A. P.; Jolles, S.; Herriot, R.; Sargur, R. B.; Arkwright, P. D.
- Abstract
Summary: Good's syndrome (thymoma and hypogammaglobulinaemia) is a rare secondary immunodeficiency disease, previously reported in the published literature as mainly individual cases or small case series. We use the national UK‐Primary Immune Deficiency (UKPID) registry to identify a large cohort of patients in the UK with this PID to review its clinical course, natural history and prognosis. Clinical information, laboratory data, treatment and outcome were collated and analysed. Seventy‐eight patients with a median age of 64 years, 59% of whom were female, were reviewed. Median age of presentation was 54 years. Absolute B cell numbers and serum immunoglobulins were very low in all patients and all received immunoglobulin replacement therapy. All patients had undergone thymectomy and nine (12%) had thymic carcinoma (four locally invasive and five had disseminated disease) requiring adjuvant radiotherapy and/or chemotherapy. CD4 T cells were significantly lower in these patients with malignant thymoma. Seventy‐four (95%) presented with infections, 35 (45%) had bronchiectasis, seven (9%) chronic sinusitis, but only eight (10%) had serious invasive fungal or viral infections. Patients with AB‐type thymomas were more likely to have bronchiectasis. Twenty (26%) suffered from autoimmune diseases (pure red cell aplasia, hypothyroidism, arthritis, myasthenia gravis, systemic lupus erythematosus, Sjögren's syndrome). There was no association between thymoma type and autoimmunity. Seven (9%) patients had died. Good's syndrome is associated with significant morbidity relating to infectious and autoimmune complications. Prospective studies are required to understand why some patients with thymoma develop persistent hypogammaglobulinaemia. Good's syndrome (thymoma and hypogammaglobulinemia is a rare secondary immunodeficiency. This is one of the largest series of patients with this condition collating information on the clinical features, laboratory parameters, complications and mortality of this disease. Prospective translational studies are required to better understand the pathogenesis of this disease.
- Subjects
UNITED Kingdom; THYMOMA; PURE red cell aplasia; MYASTHENIA gravis; SYSTEMIC lupus erythematosus; IMMUNODEFICIENCY; SEROTHERAPY; GRAFT versus host disease
- Publication
Clinical & Experimental Immunology, 2019, Vol 195, Issue 1, p132
- ISSN
0009-9104
- Publication type
Article
- DOI
10.1111/cei.13216